Literature DB >> 7864903

Secretion of Alzheimer beta/A4 protein (1-40) and intracellular retention of beta/A4 protein (1-42) in transfected COS cells.

K Maruyama1, K Tagawa, Y Kawamura, H Asada, S Ishiura, K Obata.   

Abstract

The amyloid beta/A4 protein (beta/A4) of Alzheimer disease is heterogeneous. A beta 1-40 (Asp1 to Val40) is rather soluble, whereas A beta 1-42 (Asp1 to Ala42) is more insoluble and can be the seed of deposition of A beta 1-40. Although beta/A4 itself could not be expressed transiently in COS cells by cDNA transfection, it was expressed after directly adding a signal sequence to its N-terminal end. The expressed A beta 1-40 was secreted, whereas A beta 1-42 was hardly secreted. A beta 1-40 secretion was not inhibited by metabolic inhibitors such as brefeldin A. The normally produced A beta 1-40 could not be retained intracellularly, whereas the abnormally generated A beta 1-42 might be accumulated intracellularly, resulting in cellular toxicity.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7864903     DOI: 10.1006/bbrc.1995.1280

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  5 in total

1.  Transgenic expression of intraneuronal Aβ42 but not Aβ40 leads to cellular Aβ lesions, degeneration, and functional impairment without typical Alzheimer's disease pathology.

Authors:  Dorothee Abramowski; Sabine Rabe; Ajeet Rijal Upadhaya; Julia Reichwald; Simone Danner; Dieter Staab; Estibaliz Capetillo-Zarate; Haruyasu Yamaguchi; Takaomi C Saido; Karl-Heinz Wiederhold; Dietmar Rudolf Thal; Matthias Staufenbiel
Journal:  J Neurosci       Date:  2012-01-25       Impact factor: 6.167

2.  The presenilin 2 mutation (N141I) linked to familial Alzheimer disease (Volga German families) increases the secretion of amyloid beta protein ending at the 42nd (or 43rd) residue.

Authors:  T Tomita; K Maruyama; T C Saido; H Kume; K Shinozaki; S Tokuhiro; A Capell; J Walter; J Grünberg; C Haass; T Iwatsubo; K Obata
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-04       Impact factor: 11.205

Review 3.  Toxicity of amyloid beta peptide: tales of calcium, mitochondria, and oxidative stress.

Authors:  Laura Canevari; Andrey Y Abramov; Michael R Duchen
Journal:  Neurochem Res       Date:  2004-03       Impact factor: 3.996

4.  Choroid plexus dysfunction impairs beta-amyloid clearance in a triple transgenic mouse model of Alzheimer's disease.

Authors:  Ibrahim González-Marrero; Lydia Giménez-Llort; Conrad E Johanson; Emilia María Carmona-Calero; Leandro Castañeyra-Ruiz; José Miguel Brito-Armas; Agustín Castañeyra-Perdomo; Rafael Castro-Fuentes
Journal:  Front Cell Neurosci       Date:  2015-02-06       Impact factor: 5.505

5.  Pathology associated with AAV mediated expression of beta amyloid or C100 in adult mouse hippocampus and cerebellum.

Authors:  Eleanor S Drummond; Jill Muhling; Ralph N Martins; Linda K Wijaya; Erich M Ehlert; Alan R Harvey
Journal:  PLoS One       Date:  2013-03-13       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.